2026 Japan Cell Therapy Landscape: Ventures To Gain Presence With NDAs, IPOs

Multiple Candidates Awaiting Domestic Approval

perspectives 2026

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.